Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma therapy in COVID-19 with metabolomic and laboratory evaluation
2020-005486-14Phase 4Terminated
- Sponsor
- Wroclaw Medical University
- Start
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, single-arm trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Wroclaw Medical University. Primary endpoint: Death within 28 days. Started Dec 2020; status: terminated.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-005486-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005486-14.